BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8462598)

  • 21. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular trafficking of factor VIII to von Willebrand factor storage granules.
    Rosenberg JB; Foster PA; Kaufman RJ; Vokac EA; Moussalli M; Kroner PA; Montgomery RR
    J Clin Invest; 1998 Feb; 101(3):613-24. PubMed ID: 9449695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small GTP-binding protein RalA associates with Weibel-Palade bodies in endothelial cells.
    de Leeuw HP; Wijers-Koster PM; van Mourik JA; Voorberg J
    Thromb Haemost; 1999 Sep; 82(3):1177-81. PubMed ID: 10494784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceramide triggers Weibel-Palade body exocytosis.
    Bhatia R; Matsushita K; Yamakuchi M; Morrell CN; Cao W; Lowenstein CJ
    Circ Res; 2004 Aug; 95(3):319-24. PubMed ID: 15217913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.
    Haberichter SL; Merricks EP; Fahs SA; Christopherson PA; Nichols TC; Montgomery RR
    Blood; 2005 Jan; 105(1):145-52. PubMed ID: 15331450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo and in vitro processing of recombinant pro-von Willebrand factor.
    Turecek PL; Váradi K; Schlokat U; Pichler L; Dorner F; Schwarz HP
    Histochem Cell Biol; 2002 Feb; 117(2):123-9. PubMed ID: 11935288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree.
    Gebrane-Younès J; Drouet L; Caen JP; Orcel L
    Am J Pathol; 1991 Dec; 139(6):1471-84. PubMed ID: 1750513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photosensitized release of von Willebrand factor from cultured human endothelial cells.
    Foster TH; Primavera MC; Marder VJ; Hilf R; Sporn LA
    Cancer Res; 1991 Jun; 51(12):3261-6. PubMed ID: 1828189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. von Willebrand factor released from Weibel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively.
    Sporn LA; Marder VJ; Wagner DD
    Blood; 1987 May; 69(5):1531-4. PubMed ID: 3105624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weibel-Palade bodies recruit Rab27 by a content-driven, maturation-dependent mechanism that is independent of cell type.
    Hannah MJ; Hume AN; Arribas M; Williams R; Hewlett LJ; Seabra MC; Cutler DF
    J Cell Sci; 2003 Oct; 116(Pt 19):3939-48. PubMed ID: 12928333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The von Willebrand factor propeptide (VWFpp) traffics an unrelated protein to storage.
    Haberichter SL; Jozwiak MA; Rosenberg JB; Christopherson PA; Montgomery RR
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):921-6. PubMed ID: 12067899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Von Willebrand factor targets IL-8 to Weibel-Palade bodies in an endothelial cell line.
    Romani de Wit T; de Leeuw HP; Rondaij MG; de Laaf RT; Sellink E; Brinkman HJ; Voorberg J; van Mourik JA
    Exp Cell Res; 2003 May; 286(1):67-74. PubMed ID: 12729795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential intracellular trafficking of von Willebrand factor (vWF) and vWF propeptide in porcine endothelial cells lacking Weibel-Palade bodies and in human endothelial cells.
    Royo T; Martínez-González J; Vilahur G; Badimon L
    Atherosclerosis; 2003 Mar; 167(1):55-63. PubMed ID: 12618268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells.
    Rosnoblet C; Vischer UM; Gerard RD; Irminger JC; Halban PA; Kruithof EK
    Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1796-803. PubMed ID: 10397700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. von Willebrand factor and the endothelium.
    Wagner DD; Bonfanti R
    Mayo Clin Proc; 1991 Jun; 66(6):621-7. PubMed ID: 2046401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of von willebrand factor of human endothelial cells exposed to laminar flows: an in vitro study.
    Sun RJ; Muller S; Wang X; Zhuang FY; Stoltz JF
    Clin Hemorheol Microcirc; 2000; 23(1):1-11. PubMed ID: 11214708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Storage of factor VIII variants with impaired von Willebrand factor binding in Weibel-Palade bodies in endothelial cells.
    van den Biggelaar M; Bouwens EA; Voorberg J; Mertens K
    PLoS One; 2011; 6(8):e24163. PubMed ID: 21909383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biology of von Willebrand factor].
    Girma JP
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S143-8. PubMed ID: 17373215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differing polarity of the constitutive and regulated secretory pathways for von Willebrand factor in endothelial cells.
    Sporn LA; Marder VJ; Wagner DD
    J Cell Biol; 1989 Apr; 108(4):1283-9. PubMed ID: 2494192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biogenesis of von Willebrand factor-containing organelles in heterologous transfected CV-1 cells.
    Voorberg J; Fontijn R; Calafat J; Janssen H; van Mourik JA; Pannekoek H
    EMBO J; 1993 Feb; 12(2):749-58. PubMed ID: 8440262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.